Trial Profile
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 Plus G-CSF Versus G-CSF Plus Placebo to Mobilize and Collect ≥ 5 * 10^6 CD34+ Cells/kg in Non-Hodgkin's Lymphoma Patients for Autologous Transplantation
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary) ; Filgrastim
- Indications Stem cell mobilisation
- Focus Registrational; Therapeutic Use
- Sponsors Genzyme Corporation
- 07 Apr 2014 New trial record
- 07 Apr 2014 New trial record
- 12 May 2008